- Ongoing Novel Immunotherapy Trial Builds on PACIFIC Benefits in Stage III NSCLC – OncLive
- Mutations, irAEs May Help Predict Immunotherapy Response in NSCLC – www.oncnursingnews.com/
- Glycoprotein Revealed to Be a Barrier against Cancer Immunotherapy – Genetic Engineering & Biotechnology News
- OmniSeq, UPMC Partner on Immunotherapy Trial Matching for Head and Neck Cancer – Precision Oncology News
